Hope for Parkinson's: stem cell therapy offered to patients left out of trial
NCT ID NCT06056427
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 34 times
Summary
This expanded access program offers an experimental stem cell treatment to up to 11 people with Parkinson's disease who were not chosen for the main study. The treatment uses the patient's own fat-derived stem cells given through an IV. The goal is to see if it is safe and can help control symptoms, but it is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.